STEMCELL Technologies
Scientists Helping Scientists.
|
|
| Privately held | |
| Industry | Biotechnology |
| Founded | 1993 |
| Founder | Allen Eaves |
| Headquarters | Vancouver, British Columbia, Canada |
|
Key people
|
Allen Eaves, Chairman & CEO |
|
Number of employees
|
> 800 |
| Website | www.stemcell.com |
STEMCELL Technologies Inc. is a global biotechnology company that develops, manufactures and sells products and provides services that support academic and industrial scientists. The company specializes in developing cell culture media, cell separation products, instruments and other reagents for use in stem cell, immunology, cancer, regenerative medicine and cellular therapy research. STEMCELL’s Research and Development team often collaborates with academic and industrial partners to develop, produce and distribute products specific to a given research field. STEMCELL has helped several scientific technologies born in academic research settings to reach the global biotechnology market. STEMCELL is headquartered in Vancouver, British Columbia, Canada, and has offices in eight countries including the United States, United Kingdom, Germany, France, Australia, Singapore and China, as well as distributors in approximately 80 other countries. STEMCELL is the largest biotechnology company in Canada, currently employing more than 800 people globally and offers a catalogue of more than 2,200 products.
Allen Eaves (MD, PhD, FRCPC), a hematologist and cancer researcher, co-founded the Terry Fox Laboratories (TFL) in Vancouver with his wife, Connie Eaves, in 1981. Unsatisfied with commercially available cell culture reagents, Allen Eaves’ research group at the TFL began making their own media for culturing hematopoietic stem cells. Eaves eventually began to sell the media to other research groups around the world. Production ultimately warranted building a designated clean room, which the TFL did not have the funding to provide. Instead, Eaves purchased the business from the TFL, creating an independent company with a loan from Western Economic Diversification and a mortgage on his house. STEMCELL Technologies Inc. was launched on July 2, 1993.
In its first year, STEMCELL employed eight people and, selling only cell culture media for growing hematopoietic stem cells, generated $1 million in sales. The company has since seen steady annual growth. STEMCELL has gradually expanded their product portfolio to include immune cell isolation tools as well as products that support research using pluripotent stem cells and mesenchymal stem cells. The company also sells tissue-specific products for use in neural, mammary, prostate, pulmonary, pancreatic, and intestinal cell lineages. STEMCELL’s bioengineering division develops labware and instruments and offers custom assay services.
...
Wikipedia